Mitogenic activity in connection with coronary angioplasty

S R Johansson1, J Nilsson, A Hamsten

  • 1Division of Cardiology, Sahlgrenska Hospital, University of Göteborg, Sweden.

Insights

Plasma mitogenic activity significantly increases immediately after percutaneous transluminal coronary angioplasty (PTCA). However, this acute rise in mitogenic activity does not correlate with the development of restenosis following the procedure.

Area of Science:

  • Cardiovascular Research
  • Vascular Biology
  • Interventional Cardiology

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure to treat coronary artery disease.
  • Restenosis, the re-narrowing of a blood vessel after angioplasty, remains a significant clinical challenge.
  • Plasma mitogenic activity, a marker of cellular proliferation, has been investigated for its role in vascular healing and restenosis.

Purpose of the Study:

  • To investigate the temporal changes in plasma mitogenic activity following PTCA.
  • To determine the relationship between post-PTCA plasma mitogenic activity and the occurrence of restenosis.
  • To compare plasma mitogenic activity in patients undergoing PTCA versus those undergoing diagnostic coronary angiography.

Main Methods:

  • Plasma samples were collected from 50 patients before and at multiple time points after elective PTCA (1h, 24h, 2 weeks, 6 months).
  • Mitogenic activity was assessed by measuring the incorporation of 3H-thymidine into arterial smooth muscle cells incubated with patient plasma.
  • Follow-up coronary angiography was performed to assess for restenosis at 6 months or earlier if clinically indicated. A control group of 17 patients underwent angiography without PTCA.

Main Results:

  • Plasma mitogenic activity was significantly elevated 1 hour after PTCA compared to pre-procedure levels (53.1 +/- 7.4 vs 26.8 +/- 7.3, P < 0.001).
  • Mitogenic activity returned to baseline levels by 24 hours and remained unchanged at later time points.
  • No significant increase in mitogenic activity was observed in patients undergoing coronary angiography without PTCA.
  • There was no significant difference in plasma mitogenic activity between patients who developed restenosis (n=19) and those who did not (n=31).

Conclusions:

  • Plasma mitogenic activity shows a transient, acute increase immediately following PTCA.
  • This immediate post-procedural surge in mitogenic activity is not associated with the development of restenosis.
  • The findings suggest that factors other than this acute mitogenic response are likely responsible for restenosis after PTCA.

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...